TaiwanJ Pharmaceuticals Co., Ltd.
6549
Rank in Stocks
#27393
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Share Price
$0.19052787
Last synced: 2026-11-10
Market Cap
$15.27M
Change (1 day)
0.00%
Change (1 year)
-26.09%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Category
Healthcare
Operating Margin for TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Operating Margin as of November 2026 TTM: 0.00%
According to TaiwanJ Pharmaceuticals Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for TaiwanJ Pharmaceuticals Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -29.07% | -95.37% |
| 2022 | -627.77% | 1,323.84% |
| 2021 | -44.09% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | -10.84% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin
What was TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin in 2025?
In 2025, TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin was highest in 2025 (0.00%) and lowest in 2022 (-627.77%).
How does TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin compare with similar companies?
TaiwanJ Pharmaceuticals Co., Ltd.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.